Login to Your Account



Chugai teams up with Japan's National Cancer Center, joins MASTER-KEY project

By David Ho
Staff Writer

Wednesday, August 9, 2017

HONG KONG – Japan's Chugai Pharmaceutical Co. Ltd. signed a collaborating agreement with the National Cancer Center of Japan to join forces in developing rare cancer cures and genomic medicines.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription